SlideShare a Scribd company logo
1 of 7
Download to read offline
1


         SYMPTOMATIC URINARY TRACT INFECTIONS DURING PREGNANCY

Subudhi K B, Behera Susanta Kumar, Subudhi Monalisha, Das Sudhansu Kumar,Jena
Soubhagya Kumar

Department of Obstetrics and Gynecology, MKCG Medical College, Berhampur, Orissa

ABSTRACT

Objectives: to find out the obstetric outcome symptomatic urinary tract infections in pregnancies

and type of organisms responsible for symptomatic UTI and response to treatment in those

patients. Materials & Methods: Patients with symptoms (n=100) subjected urine culture and

sensitivity and colony count. The antibiotic which is relatively safe during pregnancy, depending

upon sensitivity is implicated for that particular patient. If she is not found to be cure of

symptoms or bacteriological cure after a course of antibiotic, repeat urine culture done and

according to sensitivity repeat course of antibiotic given. Results: Common age group affected is

21-30 yrs (83%), primigravida (66%) of ‘O’ group(77%) and low SES(53%). Most of them

presented with frequency of micturition, dysuria (81%) in 3 rd trimester (60%). Among all women

66% are terminated in 28-37 wks, vaginally (82.7%) and most common organism isolated is E

coli (69%).63% women delivered babies within 2-2.5 kg, preterm contraction (22%), and

neonatal asphyxia (27%), Breast complications (15%), LBW (80%), Prematurity (60%).

Conclusion: Symptomatic urinary tract infections in pregnancy should be diagnosed and treated

early.


INTRODUCTION

            During pregnancy UTI is as high as 8% out of which 20% to 40% are symptomatic.

Recurrence of UTI in subsequent pregnancy is about 4-5% and same is risk of pyelonephritis. 1,2

A significant bacteriuria is the major risk factor for developing symptomatic urinary tract

infection during pregnancy leading to hypertension, preeclampsia, LBW, fetal wastage and
prematurity. UTI in pregnancy can take the forms of asymptomatic bacteriuria, acute

uncomplicated cystitis, urethritis, pyelonephritis.3 The organisms responsible for producing UTI

in pregnancy can be of following types:(a) Gram Negative : E.Coli in 80% of Cases, Proteus

Mirabilis, Klebsiella, (b) Gram Positive : Mycoplasma, Group-B Streptococus, Staphylococus

areus.4 Urinary tract infections are common in pregnancy due to increase susceptibility to certain

organisms, ureteral dilatation during pregnancy causing stasis of urine in the urinary tract leading

to more chance of infections. Most of the pregnant women develop glycosuria during pregnancy

which favours bacterial growth.5


MATERIAL AND METHOD


            The present study was conducted in the Department of Obstetrics and Gynecology,

MKCG Medical College, Berhampur, Orissa from October 2008 to November 2010. Patients

with symptoms (n=100) subjected for history taking and meticulous clinical examination

followed by urine culture and sensitivity and colony count. The organism isolated and the

sensitivity of antibiotic is taken into account. The safe antibiotic during pregnancy, depending

upon sensitivity is implicated for that particular patient in a standard regimen and response is

observed. She is subjected for urine culture and sensitivity within one week of completion of

antibiotic course. If the pregnant women is cured of the infection as evidenced by both clinical

and bacteriological evidence, she is advised the methods of prevention of UTI during pregnancy.

If she is not found to be cure of symptoms or bacteriological cure after a course of antibiotic,

repeat urine culture done and according to sensitivity repeat course of antibiotic given. Within

one week of completion of second course of antibiotic she is evaluated for cure, both
3


symptomatic and bacteriological. If she is not being cured she is subjected for reculture and

retreatment.




RESULTS AND DISCUSSION

           It is most common in age group of 21-30 yrs (83%) of age and 66% in primigravida,

77% in ‘O’ blood group, presented in 3-7 days in 76% and in low SES (53%). Maximum, 87%

presented with frequency of urination which is almost in agreement with that of Nkudic et al,

frequency in 80% of cases.6 It is highest in 3rd trimester of pregnancy accounting to 60%, similar

to the study conducted by Lee M et al of highest in 3 rd trimester of about 54% cases.7 Most of the

pregnancies, 66% are terminated in 28-37 wks, similar to the study of Winberg J et al reporting

28-37 weeks is 77%8.E coli is isolated in majority (69%), followed by S. areus (18%),

Pseudomonas(4%), Klebsiella(3%), Candida albicans(2%),Proteus(2%), similar result by

Rahman MA et al revealing E Coli(75%) and Staphylococcus(15%). 9 85% are not presented in

labor, among which 63% are without preterm contraction, majority and 37% with preterm

contraction. It is similar to Kass EH et al revealing, majority (70%) of without preterm

contraction.10 Here 9% cases were presented in labor. Majority, 92% of cases are having colony

count > 105 CFU per ml, 6% of 102 to 104 CFU per ml and 2% of cases have less than 10 2

CFU/ml or no growth found over 48 hrs of incubation. It is not coinciding to the study of

Onifade AK, et al revealing 98% of > 105 CFU/ml and 2% of < 105 CFU/ml.11

                              Table-I : Antepartum complications


Sl No            Ante Partum Complications              No of Cases           %

  1                 Anemia (< 7 gm %)                        4                 4

  2                                                         13                13
                   Leaking of Membrane
3                                                                  22                   22
                            Preterm Contraction
     4                             IUD                                  2                    2

     5                      Multiple Pregnancy                          1                    1




              Majority, 63% of pregnant women delivered low birth weight of 2-2.5 kg and 17% of

cases in < 2.0 kg implicating UTI as a significant contributor for this outcome. In this study 20%

cases are resulted out as > 2.5 kg, concurrent to the study done by Laura A et al reflecting 68% of

2-2.5 kg where as < 2 kg in 22% cases and > 2.5 Kg in 20% cases.12


         Table-II : Intrapartum complications                           Table-III : Postpartum complications

Sl        Intra Partum            No of                      Sl         Post Partum              No of
                                            %                                                               %
No        Complication            Cases                      No         Complication             Cases
 1         Fetal Distress              4          4          1                PPH                  2         2
             Neonatal
 2                                  27            27         2        Puerperal Pyrexia            6         6
             Asphyxia
                                                                           Breast
 3              PPH                    4          4          3                                    15        15
                                                                        Complications
 4          Eclampsia                  1          1          4          Pyelonephritis             1         1
           Instrumental
 5                                     8          8          5        Anemia (< 7 gm %)            6         6
             Delivery
          Non Progress of                                                 Chronic
 6                                     1          1          6                                     1         1
              Labor                                                     Hypertension



                Table-IV : Fetal complications                    Table-V : Sensitivity of antimicrobials

   Fetal              No of                                    E.        Klebsi     Pseudo
                                   %               Agent                                          Proteus   Candia
Complications         Case                                    Coli        ella      monas

     Abortion           2          2        Nitrofurantoin       MS         WS        R            WS        NA

 Prematurity           66         66         Amoxicillin         MS          SS       R             SS       NA
5


  Low Birth                          Cefuroxime      MS       SS       MS        WS        NA
                  80       80
   Weight

    IUGR          17       17        Amox+Clav       SS       SS       SS         SS       NA

                                     Fluconazole     NA      NA        NA        NA        SS
    IUD            3       3
                                      Pip+Tazo       SS       SS       SS         SS       NA




           Among fetal complications, low birth weight is the most common (80%), followed by

prematurity (66%) (Table-IV). Similar study conducted by Brumfitt et al showed low birth

weight (75%) and prematurity (62%) as 2nd most common complication.15. Most of the cases,

62.3% are of appropriate for gestational age (AGA), 37.7% of cases are small for gestational age

(SGA) and no case of large for gestational age (LGA) is detected. It is similar to Fihn SD et al

revealing 57% of SGA, 40% of AGA and 3% of LGA. 13The commonest ante partum

complication detected in this study is preterm contraction (22%) which is similar to study of

Naeye RL et al (Table-I). Neonatal asphyxia (27%) is highest, followed by fetal distress (4%)

indicating increased incidence of intra partum complications. (Table-II). The postpartum

complication is highest as breast complications (15%), followed by puerperal pyrexia (6%). It is

not similar to the study of Naeye RL et al which revealed that commonest postpartum

complication as puerperal pyrexia (21%) (Table-III).14Most common mode of delivery is vaginal

(82.7%), followed by LSCS (17.3%). Almost Similar study was conducted by Patton JP, et al
                                                                                                16
revealing most common mode of delivery as vaginal in 75% of cases & LSCS in 25% of cases.

Pre labor rupture of membrane is highest (47%) which is not similar with that of Valiquette et al

revealing PROM > 24 hrs accounting for 15% of cases.17


                       E Coli is strongly sensitive (SS) to Amoxicillin+Clavulinic acid &

Piperacillin+Tazobactum. Klebsiella is strongly sensitive (SS) to Amoxicillin, Cefuroxime,
Amoxicillin+Clavulunic acid and Piperacillin+Tazobactm Proteus species is strongly sensitive

(SS) to Amoxicillin, Amoxicillin+Clavulunic acid and Piperacillin+Tazobactam. Pseudomonas is

strongly sensitive (SS) to Amoxicillin+Clavulunic acid and Piperacillin+Tazobactum. All the

Candida species is strongly sensitive (SS) to Fluconazole (table-VI). It is similar to that of M R

Khatoon et al except that E Coli is strongly sensitive to Cefuroxime. Pseudomonas is weakly

sensitive to amoxicillin.


CONCLUSION

           So any evidence of symptomatic urinary tract infection during pregnancy should be

diagnosed as early as possible by urine culture and to be treated judiciously to prevent and

improve maternal and perinatal outcome of every pregnancy.


   1) Patterson TF Androl VT. Bacteriuria in Pregnancy. Infect. Dis Clin North Am. 2007; 7;

       1:807-22.

   2) Foxman : Epidemiology of Urinary tract infections, Incidence; Am J Med 2002;113:5S-

       13S

   3) Kass EH: Pyelonephritis and Bacteriuria,a major complication in Preventive

       Medicine.N. Am J. Urol; 2004; 56:46-53.

   4) Barr BJ, Ritche JW and Others , Microaerophilic/ Anerobic bacteria as a cause of

       urinary tract infections in Pregnancy, Br J Obst 7 Gyne :2005;92:506-10

   5) Lucas MJ , Cunninghams Urinary Infections in Pregnancy, Clin Obst & Gyn: 2003;

       36:855-68

   6) NKUDIC et al. National Kidney and Urologic Diseases Information Clearing House:

       Urinary Tract Infections in Adults. NIH Publication2005; No. 06-2097
7


7) Lee M, Bozzo P, Einarson A. Urinary tract infections in pregnancy. Can F. Ph. 2008;54:

   853-4

8) Winberg J. Treatment trials in urinary tract infection (UTI) with special reference to the

   effect of antimicrobials or the fecal and periurethral flora. Clin. Nephrol 2003; 1:142-8.

9) Rahman MA, Talukder SI, Khatoon MR Dinajpur et al. Med Col J ;2010 ; 3 (2):59-62

10) Kass EH. Demographic and Prognostic characteristics of bacteriuria in pregnancy. N

   Am J Med. 2007;46:385-407

11) Onifade AK. Incidence of UTIs among pregnant women attending antennal clinics in

   government hospitals in Nigeria. J. Food Agric. Environ. 3(1):2004: 37-38.

12) Laura A. Schieve, MS, Arden Handler. UTI during Pregnancy ;Br J Obste Gynecol:

   2004:32-24

13) Fihn SD. Acute uncomplicated urinary tract infections in women. N Engl J Med, 2003;

   349: 259-66

14) Naeye RL. Urinary tract infections and the outcome of pregnancy. Adv Nephrol.2006;

   15:95-102

15) Brumfitt W. The effects of bacteriuria in pregnancy on maternal and fetal health. Int

   Kidney J.2005;8:S113-S119

16) Patton JP et al. Urinary tract infection: Economic considerations. Med Cl Am 75

   (2):2009: 495-513.

17) Valiquette L. Urinary tract infections in women. Canadian journal of urology,2001,

   8(1):6

More Related Content

What's hot

Angiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsiaAngiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsiadr_indiradevi
 
Thin Endometrium Granulocyte Colony Stimulating Factor (GCSF)- What, How and...
Thin Endometrium  Granulocyte Colony Stimulating Factor (GCSF)- What, How and...Thin Endometrium  Granulocyte Colony Stimulating Factor (GCSF)- What, How and...
Thin Endometrium Granulocyte Colony Stimulating Factor (GCSF)- What, How and...Lifecare Centre
 
Alloimmune factors in recurrent pregnancy loss
Alloimmune factors in recurrent pregnancy lossAlloimmune factors in recurrent pregnancy loss
Alloimmune factors in recurrent pregnancy lossRajesh Gajbhiye
 
Thrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy LossThrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy LossMarwan Alhalabi
 
Threatened Miscarriage Verdict is out on Hormonal Treatment Dr Jyoti Agarwal
Threatened Miscarriage Verdict is out on  Hormonal Treatment Dr Jyoti AgarwalThreatened Miscarriage Verdict is out on  Hormonal Treatment Dr Jyoti Agarwal
Threatened Miscarriage Verdict is out on Hormonal Treatment Dr Jyoti AgarwalLifecare Centre
 
Hiperbilirrubinemia pediatrics in review[1]
Hiperbilirrubinemia pediatrics in review[1]Hiperbilirrubinemia pediatrics in review[1]
Hiperbilirrubinemia pediatrics in review[1]Delia Vera
 

What's hot (9)

Angiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsiaAngiogenic markers in pre eclampsia
Angiogenic markers in pre eclampsia
 
Fet endometrial preparation
Fet endometrial preparationFet endometrial preparation
Fet endometrial preparation
 
Thin Endometrium Granulocyte Colony Stimulating Factor (GCSF)- What, How and...
Thin Endometrium  Granulocyte Colony Stimulating Factor (GCSF)- What, How and...Thin Endometrium  Granulocyte Colony Stimulating Factor (GCSF)- What, How and...
Thin Endometrium Granulocyte Colony Stimulating Factor (GCSF)- What, How and...
 
Alloimmune factors in recurrent pregnancy loss
Alloimmune factors in recurrent pregnancy lossAlloimmune factors in recurrent pregnancy loss
Alloimmune factors in recurrent pregnancy loss
 
Thrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy LossThrombophilia and ٍٍRecurrent Pregnancy Loss
Thrombophilia and ٍٍRecurrent Pregnancy Loss
 
Threatened Miscarriage Verdict is out on Hormonal Treatment Dr Jyoti Agarwal
Threatened Miscarriage Verdict is out on  Hormonal Treatment Dr Jyoti AgarwalThreatened Miscarriage Verdict is out on  Hormonal Treatment Dr Jyoti Agarwal
Threatened Miscarriage Verdict is out on Hormonal Treatment Dr Jyoti Agarwal
 
Nej mcp1003896[1] copy
Nej mcp1003896[1] copyNej mcp1003896[1] copy
Nej mcp1003896[1] copy
 
Hiperbilirrubinemia pediatrics in review[1]
Hiperbilirrubinemia pediatrics in review[1]Hiperbilirrubinemia pediatrics in review[1]
Hiperbilirrubinemia pediatrics in review[1]
 
Infertility
InfertilityInfertility
Infertility
 

Viewers also liked

Urinary tract infections in obs & gynae
Urinary tract infections in obs & gynaeUrinary tract infections in obs & gynae
Urinary tract infections in obs & gynaedrmcbansal
 
Urinary tract infections during pregnancy
Urinary tract infections during pregnancyUrinary tract infections during pregnancy
Urinary tract infections during pregnancyAboubakr Elnashar
 
UTI in Pregnancy
UTI in PregnancyUTI in Pregnancy
UTI in Pregnancybajah423
 
urinary tract infection
urinary tract infectionurinary tract infection
urinary tract infectiongaestimos
 
Urinary Tract Infection
Urinary Tract InfectionUrinary Tract Infection
Urinary Tract InfectionRahul Kunkulol
 
Urinary Tract Infection (UTI)
Urinary Tract Infection (UTI)Urinary Tract Infection (UTI)
Urinary Tract Infection (UTI)Bibëk Bhandari
 

Viewers also liked (12)

Urinary tract infections in obs & gynae
Urinary tract infections in obs & gynaeUrinary tract infections in obs & gynae
Urinary tract infections in obs & gynae
 
Urinary tract infections during pregnancy
Urinary tract infections during pregnancyUrinary tract infections during pregnancy
Urinary tract infections during pregnancy
 
UTI in Pregnancy
UTI in PregnancyUTI in Pregnancy
UTI in Pregnancy
 
Urinary tract infections
Urinary tract infectionsUrinary tract infections
Urinary tract infections
 
Recurrent UTI in females
Recurrent UTI in femalesRecurrent UTI in females
Recurrent UTI in females
 
urinary tract infection
urinary tract infectionurinary tract infection
urinary tract infection
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 
Infections during pregnancy
Infections during pregnancyInfections during pregnancy
Infections during pregnancy
 
Urinary Tract Infection
Urinary Tract InfectionUrinary Tract Infection
Urinary Tract Infection
 
Urinary Tract Infection (UTI)
Urinary Tract Infection (UTI)Urinary Tract Infection (UTI)
Urinary Tract Infection (UTI)
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 

Similar to Symtomatic urinary tract infections during pregnancy

Clinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreClinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreiosrjce
 
Miscarriage
MiscarriageMiscarriage
MiscarriageEneutron
 
Tra ecoinicial master
Tra ecoinicial masterTra ecoinicial master
Tra ecoinicial masterger15969
 
13. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 1513. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 15Pawan KB Agrawal
 
1. recurrent pregnancy loss
1. recurrent pregnancy loss  1. recurrent pregnancy loss
1. recurrent pregnancy loss DrRokeyaBegum
 
Outcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patientsOutcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patientsescts2012
 
"Internal podalic version- revival of a disappearing art"
"Internal podalic version- revival of a disappearing art""Internal podalic version- revival of a disappearing art"
"Internal podalic version- revival of a disappearing art"Charu Mittal
 
Recurrent pregnancy loss 1
Recurrent pregnancy loss 1Recurrent pregnancy loss 1
Recurrent pregnancy loss 1drmcbansal
 
Recurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptxRecurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptxPuiteaChhangte
 
An update on recurrent pregnancy loss 2015
An update on  recurrent pregnancy loss 2015An update on  recurrent pregnancy loss 2015
An update on recurrent pregnancy loss 2015Lifecare Centre
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptxDrRokeyaBegum
 
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS           Prof. Aboubakr ElnasharART PREGNANCY COMPLICATIONS           Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS Prof. Aboubakr ElnasharAboubakr Elnashar
 
Multiple pregnancy by tanoj patidar
Multiple pregnancy by tanoj patidarMultiple pregnancy by tanoj patidar
Multiple pregnancy by tanoj patidarTanoj Patidar
 
Preventing preterm labour
Preventing preterm labourPreventing preterm labour
Preventing preterm labourlimgengyan
 
Preventing preterm labour
Preventing preterm labourPreventing preterm labour
Preventing preterm labourlimgengyan
 
antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing Dr Praman Kushwah
 
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfAbortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfJulioJulia3
 

Similar to Symtomatic urinary tract infections during pregnancy (20)

Clinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centreClinical study of Eclampsia and outcome in a tertiary care centre
Clinical study of Eclampsia and outcome in a tertiary care centre
 
Miscarriage
MiscarriageMiscarriage
Miscarriage
 
Tra ecoinicial master
Tra ecoinicial masterTra ecoinicial master
Tra ecoinicial master
 
13. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 1513. intrahepatic cholestasis of pregnancy3rd jun 15
13. intrahepatic cholestasis of pregnancy3rd jun 15
 
1. recurrent pregnancy loss
1. recurrent pregnancy loss  1. recurrent pregnancy loss
1. recurrent pregnancy loss
 
Outcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patientsOutcome of pregnancy in prosthetic valve patients
Outcome of pregnancy in prosthetic valve patients
 
"Internal podalic version- revival of a disappearing art"
"Internal podalic version- revival of a disappearing art""Internal podalic version- revival of a disappearing art"
"Internal podalic version- revival of a disappearing art"
 
ART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONSART PREGNANCY COMPLICATIONS
ART PREGNANCY COMPLICATIONS
 
Recurrent pregnancy loss 1
Recurrent pregnancy loss 1Recurrent pregnancy loss 1
Recurrent pregnancy loss 1
 
Murray2005
Murray2005Murray2005
Murray2005
 
Recurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptxRecurrent pregnancy loss.pptx
Recurrent pregnancy loss.pptx
 
An update on recurrent pregnancy loss 2015
An update on  recurrent pregnancy loss 2015An update on  recurrent pregnancy loss 2015
An update on recurrent pregnancy loss 2015
 
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
Controversy and consensus regarding  management of recurrent pregnancy loss.pptxControversy and consensus regarding  management of recurrent pregnancy loss.pptx
Controversy and consensus regarding management of recurrent pregnancy loss.pptx
 
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS           Prof. Aboubakr ElnasharART PREGNANCY COMPLICATIONS           Prof. Aboubakr Elnashar
ART PREGNANCY COMPLICATIONS Prof. Aboubakr Elnashar
 
Multiple pregnancy by tanoj patidar
Multiple pregnancy by tanoj patidarMultiple pregnancy by tanoj patidar
Multiple pregnancy by tanoj patidar
 
Prenatal cytogenetic
Prenatal cytogenetic Prenatal cytogenetic
Prenatal cytogenetic
 
Preventing preterm labour
Preventing preterm labourPreventing preterm labour
Preventing preterm labour
 
Preventing preterm labour
Preventing preterm labourPreventing preterm labour
Preventing preterm labour
 
antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing antenatal assessment of Fetal wellbeing
antenatal assessment of Fetal wellbeing
 
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdfAbortions_Dohbit-/$/7:8_Yaounde_2007.pdf
Abortions_Dohbit-/$/7:8_Yaounde_2007.pdf
 

More from susanta12

Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxsusanta12
 
Hyperemesis gravidarum
Hyperemesis gravidarumHyperemesis gravidarum
Hyperemesis gravidarumsusanta12
 
Anemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapyAnemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapysusanta12
 
Symtomatic urinary tract infections during pregnancy
Symtomatic urinary tract infections during pregnancySymtomatic urinary tract infections during pregnancy
Symtomatic urinary tract infections during pregnancysusanta12
 
Hellp syndrome
Hellp syndromeHellp syndrome
Hellp syndromesusanta12
 

More from susanta12 (6)

Gestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptxGestational Diabetes Mellitus.pptx
Gestational Diabetes Mellitus.pptx
 
Hyperemesis gravidarum
Hyperemesis gravidarumHyperemesis gravidarum
Hyperemesis gravidarum
 
Anemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapyAnemia in pregnancy &role of parenteral iron therapy
Anemia in pregnancy &role of parenteral iron therapy
 
Symtomatic urinary tract infections during pregnancy
Symtomatic urinary tract infections during pregnancySymtomatic urinary tract infections during pregnancy
Symtomatic urinary tract infections during pregnancy
 
Hellp syndrome
Hellp syndromeHellp syndrome
Hellp syndrome
 
Eclampsia
EclampsiaEclampsia
Eclampsia
 

Symtomatic urinary tract infections during pregnancy

  • 1. 1 SYMPTOMATIC URINARY TRACT INFECTIONS DURING PREGNANCY Subudhi K B, Behera Susanta Kumar, Subudhi Monalisha, Das Sudhansu Kumar,Jena Soubhagya Kumar Department of Obstetrics and Gynecology, MKCG Medical College, Berhampur, Orissa ABSTRACT Objectives: to find out the obstetric outcome symptomatic urinary tract infections in pregnancies and type of organisms responsible for symptomatic UTI and response to treatment in those patients. Materials & Methods: Patients with symptoms (n=100) subjected urine culture and sensitivity and colony count. The antibiotic which is relatively safe during pregnancy, depending upon sensitivity is implicated for that particular patient. If she is not found to be cure of symptoms or bacteriological cure after a course of antibiotic, repeat urine culture done and according to sensitivity repeat course of antibiotic given. Results: Common age group affected is 21-30 yrs (83%), primigravida (66%) of ‘O’ group(77%) and low SES(53%). Most of them presented with frequency of micturition, dysuria (81%) in 3 rd trimester (60%). Among all women 66% are terminated in 28-37 wks, vaginally (82.7%) and most common organism isolated is E coli (69%).63% women delivered babies within 2-2.5 kg, preterm contraction (22%), and neonatal asphyxia (27%), Breast complications (15%), LBW (80%), Prematurity (60%). Conclusion: Symptomatic urinary tract infections in pregnancy should be diagnosed and treated early. INTRODUCTION During pregnancy UTI is as high as 8% out of which 20% to 40% are symptomatic. Recurrence of UTI in subsequent pregnancy is about 4-5% and same is risk of pyelonephritis. 1,2 A significant bacteriuria is the major risk factor for developing symptomatic urinary tract infection during pregnancy leading to hypertension, preeclampsia, LBW, fetal wastage and
  • 2. prematurity. UTI in pregnancy can take the forms of asymptomatic bacteriuria, acute uncomplicated cystitis, urethritis, pyelonephritis.3 The organisms responsible for producing UTI in pregnancy can be of following types:(a) Gram Negative : E.Coli in 80% of Cases, Proteus Mirabilis, Klebsiella, (b) Gram Positive : Mycoplasma, Group-B Streptococus, Staphylococus areus.4 Urinary tract infections are common in pregnancy due to increase susceptibility to certain organisms, ureteral dilatation during pregnancy causing stasis of urine in the urinary tract leading to more chance of infections. Most of the pregnant women develop glycosuria during pregnancy which favours bacterial growth.5 MATERIAL AND METHOD The present study was conducted in the Department of Obstetrics and Gynecology, MKCG Medical College, Berhampur, Orissa from October 2008 to November 2010. Patients with symptoms (n=100) subjected for history taking and meticulous clinical examination followed by urine culture and sensitivity and colony count. The organism isolated and the sensitivity of antibiotic is taken into account. The safe antibiotic during pregnancy, depending upon sensitivity is implicated for that particular patient in a standard regimen and response is observed. She is subjected for urine culture and sensitivity within one week of completion of antibiotic course. If the pregnant women is cured of the infection as evidenced by both clinical and bacteriological evidence, she is advised the methods of prevention of UTI during pregnancy. If she is not found to be cure of symptoms or bacteriological cure after a course of antibiotic, repeat urine culture done and according to sensitivity repeat course of antibiotic given. Within one week of completion of second course of antibiotic she is evaluated for cure, both
  • 3. 3 symptomatic and bacteriological. If she is not being cured she is subjected for reculture and retreatment. RESULTS AND DISCUSSION It is most common in age group of 21-30 yrs (83%) of age and 66% in primigravida, 77% in ‘O’ blood group, presented in 3-7 days in 76% and in low SES (53%). Maximum, 87% presented with frequency of urination which is almost in agreement with that of Nkudic et al, frequency in 80% of cases.6 It is highest in 3rd trimester of pregnancy accounting to 60%, similar to the study conducted by Lee M et al of highest in 3 rd trimester of about 54% cases.7 Most of the pregnancies, 66% are terminated in 28-37 wks, similar to the study of Winberg J et al reporting 28-37 weeks is 77%8.E coli is isolated in majority (69%), followed by S. areus (18%), Pseudomonas(4%), Klebsiella(3%), Candida albicans(2%),Proteus(2%), similar result by Rahman MA et al revealing E Coli(75%) and Staphylococcus(15%). 9 85% are not presented in labor, among which 63% are without preterm contraction, majority and 37% with preterm contraction. It is similar to Kass EH et al revealing, majority (70%) of without preterm contraction.10 Here 9% cases were presented in labor. Majority, 92% of cases are having colony count > 105 CFU per ml, 6% of 102 to 104 CFU per ml and 2% of cases have less than 10 2 CFU/ml or no growth found over 48 hrs of incubation. It is not coinciding to the study of Onifade AK, et al revealing 98% of > 105 CFU/ml and 2% of < 105 CFU/ml.11 Table-I : Antepartum complications Sl No Ante Partum Complications No of Cases % 1 Anemia (< 7 gm %) 4 4 2 13 13 Leaking of Membrane
  • 4. 3 22 22 Preterm Contraction 4 IUD 2 2 5 Multiple Pregnancy 1 1 Majority, 63% of pregnant women delivered low birth weight of 2-2.5 kg and 17% of cases in < 2.0 kg implicating UTI as a significant contributor for this outcome. In this study 20% cases are resulted out as > 2.5 kg, concurrent to the study done by Laura A et al reflecting 68% of 2-2.5 kg where as < 2 kg in 22% cases and > 2.5 Kg in 20% cases.12 Table-II : Intrapartum complications Table-III : Postpartum complications Sl Intra Partum No of Sl Post Partum No of % % No Complication Cases No Complication Cases 1 Fetal Distress 4 4 1 PPH 2 2 Neonatal 2 27 27 2 Puerperal Pyrexia 6 6 Asphyxia Breast 3 PPH 4 4 3 15 15 Complications 4 Eclampsia 1 1 4 Pyelonephritis 1 1 Instrumental 5 8 8 5 Anemia (< 7 gm %) 6 6 Delivery Non Progress of Chronic 6 1 1 6 1 1 Labor Hypertension Table-IV : Fetal complications Table-V : Sensitivity of antimicrobials Fetal No of E. Klebsi Pseudo % Agent Proteus Candia Complications Case Coli ella monas Abortion 2 2 Nitrofurantoin MS WS R WS NA Prematurity 66 66 Amoxicillin MS SS R SS NA
  • 5. 5 Low Birth Cefuroxime MS SS MS WS NA 80 80 Weight IUGR 17 17 Amox+Clav SS SS SS SS NA Fluconazole NA NA NA NA SS IUD 3 3 Pip+Tazo SS SS SS SS NA Among fetal complications, low birth weight is the most common (80%), followed by prematurity (66%) (Table-IV). Similar study conducted by Brumfitt et al showed low birth weight (75%) and prematurity (62%) as 2nd most common complication.15. Most of the cases, 62.3% are of appropriate for gestational age (AGA), 37.7% of cases are small for gestational age (SGA) and no case of large for gestational age (LGA) is detected. It is similar to Fihn SD et al revealing 57% of SGA, 40% of AGA and 3% of LGA. 13The commonest ante partum complication detected in this study is preterm contraction (22%) which is similar to study of Naeye RL et al (Table-I). Neonatal asphyxia (27%) is highest, followed by fetal distress (4%) indicating increased incidence of intra partum complications. (Table-II). The postpartum complication is highest as breast complications (15%), followed by puerperal pyrexia (6%). It is not similar to the study of Naeye RL et al which revealed that commonest postpartum complication as puerperal pyrexia (21%) (Table-III).14Most common mode of delivery is vaginal (82.7%), followed by LSCS (17.3%). Almost Similar study was conducted by Patton JP, et al 16 revealing most common mode of delivery as vaginal in 75% of cases & LSCS in 25% of cases. Pre labor rupture of membrane is highest (47%) which is not similar with that of Valiquette et al revealing PROM > 24 hrs accounting for 15% of cases.17 E Coli is strongly sensitive (SS) to Amoxicillin+Clavulinic acid & Piperacillin+Tazobactum. Klebsiella is strongly sensitive (SS) to Amoxicillin, Cefuroxime,
  • 6. Amoxicillin+Clavulunic acid and Piperacillin+Tazobactm Proteus species is strongly sensitive (SS) to Amoxicillin, Amoxicillin+Clavulunic acid and Piperacillin+Tazobactam. Pseudomonas is strongly sensitive (SS) to Amoxicillin+Clavulunic acid and Piperacillin+Tazobactum. All the Candida species is strongly sensitive (SS) to Fluconazole (table-VI). It is similar to that of M R Khatoon et al except that E Coli is strongly sensitive to Cefuroxime. Pseudomonas is weakly sensitive to amoxicillin. CONCLUSION So any evidence of symptomatic urinary tract infection during pregnancy should be diagnosed as early as possible by urine culture and to be treated judiciously to prevent and improve maternal and perinatal outcome of every pregnancy. 1) Patterson TF Androl VT. Bacteriuria in Pregnancy. Infect. Dis Clin North Am. 2007; 7; 1:807-22. 2) Foxman : Epidemiology of Urinary tract infections, Incidence; Am J Med 2002;113:5S- 13S 3) Kass EH: Pyelonephritis and Bacteriuria,a major complication in Preventive Medicine.N. Am J. Urol; 2004; 56:46-53. 4) Barr BJ, Ritche JW and Others , Microaerophilic/ Anerobic bacteria as a cause of urinary tract infections in Pregnancy, Br J Obst 7 Gyne :2005;92:506-10 5) Lucas MJ , Cunninghams Urinary Infections in Pregnancy, Clin Obst & Gyn: 2003; 36:855-68 6) NKUDIC et al. National Kidney and Urologic Diseases Information Clearing House: Urinary Tract Infections in Adults. NIH Publication2005; No. 06-2097
  • 7. 7 7) Lee M, Bozzo P, Einarson A. Urinary tract infections in pregnancy. Can F. Ph. 2008;54: 853-4 8) Winberg J. Treatment trials in urinary tract infection (UTI) with special reference to the effect of antimicrobials or the fecal and periurethral flora. Clin. Nephrol 2003; 1:142-8. 9) Rahman MA, Talukder SI, Khatoon MR Dinajpur et al. Med Col J ;2010 ; 3 (2):59-62 10) Kass EH. Demographic and Prognostic characteristics of bacteriuria in pregnancy. N Am J Med. 2007;46:385-407 11) Onifade AK. Incidence of UTIs among pregnant women attending antennal clinics in government hospitals in Nigeria. J. Food Agric. Environ. 3(1):2004: 37-38. 12) Laura A. Schieve, MS, Arden Handler. UTI during Pregnancy ;Br J Obste Gynecol: 2004:32-24 13) Fihn SD. Acute uncomplicated urinary tract infections in women. N Engl J Med, 2003; 349: 259-66 14) Naeye RL. Urinary tract infections and the outcome of pregnancy. Adv Nephrol.2006; 15:95-102 15) Brumfitt W. The effects of bacteriuria in pregnancy on maternal and fetal health. Int Kidney J.2005;8:S113-S119 16) Patton JP et al. Urinary tract infection: Economic considerations. Med Cl Am 75 (2):2009: 495-513. 17) Valiquette L. Urinary tract infections in women. Canadian journal of urology,2001, 8(1):6